45 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
Act and the rules of the Public Company Accounting Oversight Board (“PCAOB”), (ii) in compliance with the applicable requirements relating
8-K
EX-10.1
i7d 3dufvf
21 Mar 22
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results
8:11am